# Vanda Pharmaceuticals Inc.: Form 8-K, filed Dec 31, 2025

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2025-12-31
- Accepted by EDGAR: Dec 30, 2025, 18:45 ET
- Period: 2025-12-30
- Accession: 0001628280-25-059155
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/vnda-20251230.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/vnda-20251230.htm

Filed Dec 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-059155. Last ingested by Listed: Oct 29, 2026, 08:08 ET. No prices; not investment advice.